Skip to content
Medical Health Aged Care

Inclusive funding key to improve health and wellbeing for Australians with disability

Royal Australian College of GPs 2 mins read

Access to more funding for essential GP care is key to improve health and wellbeing for Australians with disability, says the Royal Australian College of GPs (RACGP). 

The call comes on International Day of People with Disability, 3 December. 

RACGP President Michael Wright said: “GPs play an important role in providing care for people with disabilitiesthe trusted relationship patients have with their GP often starts before diagnosis and goes through their entire journey, as we help people navigate the complexity in their lives and in our health system.    

In Australia, 1 in 6 people experience significant disability. We can and should do more to improve their health and wellbeing. 

The government must ensure general practice care is accessible and affordable. Most importantly we need more funding for the longer appointments that people with disability and complex health issues need. 

GPs coordinate care for their patients making sure they get the right care at the right time from other specialists, allied health and support services. GPs also spend a lot of time on administrative paperwork and reports for the NDIS - often unpaid. 

GP care needs to be better supported by government funding so people with disabilities can get high-quality care and live their best lives.” 

Dr Melita Cullen is a Queensland GP living with autism and dyslexia and sees many patients with disability. 

“GPs with disabilities are perfectly placed to advocate in their communities and with decision makers. We know that a person’s disability affects every area of their lives and have insight into the challenges our patients face.  

“I love working with my patients, but we need better funding to reduce the barriers for patients with disabilities. The financial barriers my patients face, and low government funding for longer consultations, means they need to see me more frequently, which costs them in time, transport and carers who need to attend too.  

“In order to provide optimal care for people with disabilities we need more inclusive funding strategies, including more funding for longer consults, non-face-to-face patient care and longer telephone consultations which ensure access for people with mobility issues. 

“This is key to reduce the barriers to essential GP care for people with disability and improve their health and wellbeing.” 

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992[email protected]

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 16/06/2026
  • 22:47
Optimi Health Corp.

Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research

Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studiesNew microdose formats extend Optimi's psilocybin range, which includes a 5mg formulation currently commercially prescribed for treatment-resistant depression in Australia under the country's Authorized Prescriber SchemeVANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN0) (the "Company" or "Optimi"), a commercial-stage GMP pharmaceutical manufacturer of regulated psychedelic drug products, today announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and 2 mg dosages. The products…

  • Medical Health Aged Care
  • 16/06/2026
  • 14:30
Dementia Australia

Brisbane comes together for people impacted by dementia

Brisbane community members tied up their laces and showed up in force last weekend for the 2026 Brisbane Memory Walk & Jog - throwing their support behind people impacted by dementia whilst getting active to improve their brain health. More than 1,470 people walked, ran and jogged to the finish line to raise an impressive total of $195,098. Dementia Australia CEO Professor Tanya Buchanan extended her gratitude to all who participated, volunteered and raised vital funds for the cause. “There was an incredible turnout from the Brisbane community this year yet again, in support of the many people impacted by…

  • Contains:
  • Biotechnology, Medical Health Aged Care
  • 16/06/2026
  • 09:51
ENA Respiratory

ENA Respiratory Receives USPTO Notice of Allowance for Two Patents Covering TLR2 Agonists and Rhinovirus-Mediated COPD Exacerbations

Melbourne, Australia, 15 June 2026 – ENA Respiratory, a clinical-stage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in at-risk populations, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for two patent applications notably a composition-of-matter patent and method-of-use for its Toll-like receptor 2 (TLR2) therapies. A composition-of-matter patent (US 17/622,451, "A series of TLR2 agonist compounds") and A method-of-use patent for the treatment of rhinovirus-mediated exacerbations of chronic obstructive pulmonary disease (COPD) (US 16/495,829, "Methods of treating rhinovirus-mediated exacerbations of COPD…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.